Researchers at the University of Cambridge have taken the first step towards developing a new form of treatment for type 1 diabetes which, if successful, could mean an end to the regular insulin injections endured by people affected by the disease, many of whom are children.
Technology assisting people with type 1 diabetes edges closer to perfection.
Our immune systems vary with the seasons, according to a study led by the University of Cambridge that could help explain why certain conditions such as heart disease and rheumatoid arthritis are aggravated in winter whilst people tend to be healthier in the summer.
The success of a clinical trial hinges on its ability to recruit enough patients. Dr Frank Waldron-Lynch from the Cambridge Institute for Medical Research explains how the use of the internet to directly contact patients with type 1 diabetes greatly accelerated the recruitment leading to the early completion of his team’s study of a potential new treatment for type 1 diabetes.
Children with type 1 diabetes have been able to use pioneering artificial pancreas technology, developed at the University of Cambridge, for the first time overnight at home without the supervision of researchers.